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A B S T R A C T
Cerebral small vessel disease (SVD) is the primary cause of vascular cognitive impairment and is associated with
decline in executive function (EF) and information processing speed (IPS). Imaging biomarkers are needed that
can monitor and identify individuals at risk of severe cognitive decline. Recently there has been interest in
combining several magnetic resonance imaging (MRI) markers of SVD into a unitary score to describe disease
severity. Here we apply a diﬀusion tensor image (DTI) segmentation technique (DSEG) to describe SVD related
changes in a single unitary score across the whole cerebrum, to investigate its relationship with cognitive change
over a three-year period.
98 patients (aged 43–89) with SVD underwent annual MRI scanning and cognitive testing for up to three
years. DSEG provides a vector of 16 discrete segments describing brain microstructure of healthy and/or da-
maged tissue. By calculating the scalar product of each DSEG vector in reference to that of a healthy ageing
control we generate an angular measure (DSEG θ) describing the patients' brain tissue microstructural similarity
to a disease free model of a healthy ageing brain. Conventional MRI markers of SVD brain change were also
assessed including white matter hyperintensities, cerebral atrophy, incident lacunes, cerebral-microbleeds, and
white matter microstructural damage measured by DTI histogram parameters. The impact of brain change on
cognition was explored using linear mixed-eﬀects models. Post-hoc sample size analysis was used to assess the
viability of DSEG θ as a tool for clinical trials.
Changes in brain structure described by DSEG θ were related to change in EF and IPS (p< 0.001) and
remained signiﬁcant in multivariate models including other MRI markers of SVD as well as age, gender and
premorbid IQ. Of the conventional markers, presence of new lacunes was the only marker to remain a signiﬁcant
predictor of change in EF and IPS in the multivariate models (p= 0.002). Change in DSEG θ was also related to
change in all other MRI markers (p< 0.017), suggesting it may be used as a surrogate marker of SVD damage
across the cerebrum. Sample size estimates indicated that fewer patients would be required to detect treatment
eﬀects using DSEG θ compared to conventional MRI and DTI markers of SVD severity.
DSEG θ is a powerful tool for characterising subtle brain change in SVD that has a negative impact on
cognition and remains a signiﬁcant predictor of cognitive change when other MRI markers of brain change are
accounted for. DSEG provides an automatic segmentation of the whole cerebrum that is sensitive to a range of
SVD related structural changes and successfully predicts cognitive change. Power analysis shows DSEG θ has
potential as a monitoring tool in clinical trials. As such it may provide a marker of SVD severity from a single
imaging modality (i.e. DTIs).
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1. Introduction
Cerebral small vessel disease (SVD) is a disease of the small per-
forating arteries and capillaries and results in tissue damage to the
subcortical grey matter (GM) and white matter (WM) (Pantoni, 2010).
SVD presents clinically with lacunar strokes (a result of blockage of the
perforating arteries) and is the primary cause of vascular cognitive
impairment (Wardlaw et al., 2013b). The course of SVD is hetero-
geneous and individuals may remain stable for a period of time or
demonstrate a rapid decline in cognitive function (Lawrence et al.,
2015). A goal of MRI research in SVD is to develop imaging biomarkers
that can predict which individuals are at risk for greater decline, in
order to target interventions at those who will beneﬁt most.
MRI methods have been applied to measure brain changes and
predict decline in function in SVD (Wardlaw et al., 2013a, 2013b). T1-
weighted images are typically used to examine whole brain atrophy as
well as atrophy of grey matter (GM); T2-weighted or ﬂuid-attenuated
inversion recovery (FLAIR) images are used to quantify white matter
hyperintensity (WMH) volume and presence of lacunar infarcts; T2*
identify cerebral microbleeds (CMB); and diﬀusion tensor images (DTI)
quantify white matter (WM) microstructure. Each of these measures has
been associated with cognition in SVD, and particularly in the domains
of executive function (EF) and information processing speed (IPS),
which are aﬀected early in the disease.
Whole brain atrophy is a feature of SVD, with the rate of volume loss
exceeding that observed in healthy ageing (Nitkunan et al., 2011).
Higher rates of atrophy are associated with increased decline in EF and
IPS over a 3-year period (Jokinen et al., 2012). WMH and lacunar in-
farcts have also been associated with cognitive diﬃculties in SVD
(Benisty et al., 2009; Benjamin et al., 2015; van den Heuvel et al., 2006;
Lawrence et al., 2013; Schmidt et al., 2012). CMB have demonstrated a
weak association with EF in SVD (Patel et al., 2013; Yamashiro et al.,
2014). Decreased fractional anisotropy (FA) and increased mean dif-
fusivity (MD) in normal appearing white matter is associated with
poorer performance in EF and IPS, and associations with cognition are
stronger for DTI metrics than for WMH, lacune volume and brain vo-
lume (Baykara et al., 2016; Nitkunan et al., 2008; O'Sullivan et al.,
2004 & Tuladhar et al., 2015).
The relationships reported between single imaging biomarkers of
SVD and cognition are often weak and research has suggested that
combining multiple MRI metrics may provide the most accurate pre-
dictions of cognitive decline. For example, Baune et al. (2009) have
shown that the presence of both WMH and incident lacunes has a larger
negative impact on IPS and episodic memory (EM) than the presence of
just one type of lesion. Supporting this, Jokinen et al. (2011) reported
independent contributions of WMH and incident lacunes in predicting
decline in EF and IPS. As MRI markers of SVD are often co-occur in
individuals, recent eﬀorts have been made to combine them into a
unitary score of SVD burden (Huijts et al., 2013; Klarenbeek et al.,
2013; Staals et al., 2015; Staals et al., 2014). Huijts et al. (2013) and
Staals et al. (2014) used a score of SVD burden in which the presence of
WMH, CMB, perivascular spaces and lacunar infarcts was summed to
create a score between 0 and 4. Huijts et al. found that increased SVD
burden as measured by this accumulation score was related to EF, IPS,
EM and global cognition in participants at risk of SVD. Staals et al.
(2015) used the same SVD burden score in a cohort of older participants
and found that increases in combined MRI features of SVD were related
to poorer general cognitive performance. They extended these ﬁndings
by performing latent variable modelling to show that the four MRI
features formed a unitary SVD construct and this latent construct was
also related to cognitive performance.
However, multimodal MRI metrics require both longer scanning
time (which may be uncomfortable for patients with SVD especially as
cognitive diﬃculties increase) and complex post-processing (Wardlaw
et al., 2013a, 2013b). For a biomarker to be eﬀective it should provide
good predictive validity, be easy to acquire, and be useful across
diﬀerent scanners or sites (for use in multi-centre trials). Here, we
propose a framework for the application of a whole cerebrum diﬀusion
tensor image segmentation technique (Jones et al., 2014) that focuses
on one imaging modality and, simultaneously includes isotropic and
anisotropic diﬀusion metrics. The framework: i) provides information
on whole brain microstructure that usefully describes a summary score
related to brain tissue changes in SVD, ii) produces metrics that are
associated with cognitive diﬃculties in SVD, and iii) provides useful
predictive information regarding cognitive decline. In this study we
apply a diﬀusion tensor image segmentation technique (DSEG) to a
longitudinal sample of patients with SVD to examine diﬀerences in
brain tissue diﬀusion proﬁles across the whole cerebrum, and associa-
tions with cognition. We hypothesise that across the cerebrum the
percentage of DSEG segments representing healthy tissue will decrease
over time, while segments representing damaged tissue will increase.
We hypothesise that these changes will be related to change in EF and
IPS. Finally we postulate that subject speciﬁc levels of GM atrophy and
WM microstructural decline will be reﬂected in a summary metric,
which will be signiﬁcantly associated with decline in EF and IPS.
2. Methods
2.1. Participants
2.1.1. SVD participants
Patients presenting with symptomatic SVD were recruited as part of
the St George's Cognition And Neuroimaging in Stroke (SCANS) study.
Recruitment occurred between 2007 and 2010 at three stroke services
in hospitals covering a geographically contiguous area in South London,
UK; St George's Hospital, King's College Hospital and St Thomas'
Hospital. This data set has been described previously (Benjamin et al.,
2015; Lambert et al., 2015; Lawrence et al., 2013; Zeestraten et al.,
2016). Inclusion criteria comprised of a clinical lacunar stroke syn-
drome (Bamford et al., 1987) with radiological evidence of an anato-
mically corresponding lacunar infarct <=1.5 cm diameter. In addi-
tion, inclusion criteria required conﬂuent regions of WMH as graded
two or more on the modiﬁed Fazekas scale (Fazekas et al., 1987; Hassan
et al., 2003) and ﬂuency in English suﬃcient to enable cognitive
testing. Exclusion criteria were: contra-indications to undergo MRI
scanning, any cause of stroke other than SVD (e.g. large artery stroke
and cardioembolic stroke), current or history of central nervous system
or major psychiatric disorder excluding migraine and depression, and
any cause of white matter disease other than SVD. When new clinical
strokes occurred during follow-up, patients remained eligible for the
study providing the stroke was lacunar. Patients were recruited at least
three months after last stroke occurrence to avoid the inﬂuence of any
acute ischaemic eﬀects on cognitive performance and MRI measures.
Patients were followed up annually with repeat MRI and cognitive
testing for three years. At each follow-up visit, repeat recording of
cardiovascular risk factors and blood pressure measurements was per-
formed. The study was approved by the Wandsworth (London) research
ethics committee and all patients provided written informed consent.
The study was registered with the UK clinical research network (http://
public.ukcrn.org.uk/, study ID: 4577).
2.1.2. Available SVD data
At baseline a total of 121 patients were recruited. Of these 103 at-
tended more than one cognitive assessment. Eighteen patients only
attended one assessment due to death (n = 7), formal study withdrawal
(n = 6), house move (n = 1), lost to follow-up (n = 2) and withdrawal
from full neuropsychological testing (n = 2). Of the 103 patients who
attended cognitive assessments more than once, MRI and neu-
ropsychological data at multiple time points was available for 98 SVD
patients (mean age = 68.42, SD = 9.98, range = 43–88, male = 65).
Demographic baseline characteristics of the 98 patients who attended
one or more follow-up are described in Table 1.
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2.1.3. Healthy ageing data
MRI data acquired was also available for a sample of healthy older
adults. Participants were recruited to the St. George's Neuropsychology
and Imaging in the Elderly (GENIE) longitudinal study. MRI data acquired
at the third assessment was acquired using the same acquisition protocol
on the same scanner as the SVD data. Full details of this sample have been
described previously (Charlton et al., 2006; Charlton et al., 2013; Charlton
et al., 2010). Brieﬂy, 112 participants aged 50–90 years (mean age 69; 55
male) were recruited via local family doctors by random sampling, and
were screened for MRI contraindications and prior psychiatric or neuro-
logical disorders; all spoke English as their ﬁrst language. At the third time
point (data included in the current DSEG analysis), good quality MRI data
was available for 52 participants (mean age = 72.31, SD= 9.97, ran-
ge = 53–91 years; male, n = 34) using the MRI acquisition as for the SVD
data. The healthy ageing MRI data was included in the study to provide
suﬃcient information for the DSEG technique to identify both healthy and
damaged tissue in the DTI segmentation. Healthy ageing data was in-
cluded to improve characterisation of the (p, q) space by providing a larger
spectrum of diﬀusion proﬁles reﬂecting healthy to damaged brain tissue.
The inclusion of healthy ageing controls in the DSEG processing also al-
lowed for the use of a healthy ageing brain as the reference point in order
to calculate DSEG θ (see Section 2.4.6). No group comparisons between
healthy ageing and SVD patients were performed in this study. For group
comparisons see Lawrence et al. (2013) where it was reported that there
were no diﬀerences in age or gender between the SCANS and GENIE co-
horts.
2.2. Magnetic resonance image acquisition
MR images were acquired using a 1.5-Tesla GE Signa HDxt system
(General Electric, Milwaukee, WI, USA) with maximum gradient am-
plitude of 33 mT/m and a proprietary head coil. To standardise head
position, patients were placed in a neutral position in the head coil with
an alignment marker at the nasal bridge. To minimise head movement
foam pads and a Velcro strap across the forehead were used. Total
imaging time was approximately 45 min during which the following
scan sequences, all providing whole head coverage, were obtained: 3D
T1-weighted spoiled gradient recalled echo, FLAIR, T2*-weighted gra-
dient recalled echo and single shot spin echo planar diﬀusion-weighted
imaging (Benjamin et al., 2015; Lawrence et al., 2013; Zeestraten et al.,
2016). Although the DSEG method described here relies on only DTI,
other imaging modalities are included for comparison purposes.
DTI were acquired using the following parameters: -
acquisition matrix = 96 × 96, ﬁeld of view (FOV) = 240 × 240 mm2,
TE = 93.4 ms, TR = 15,600 ms, 55 slices without any slice gaps to
provide an isotropic voxel resolution of 2.5 × 2.5 × 2.5 mm3, max-
imum b value = 1000 s mm−2. Diﬀusion-weighted spin echo planar
images were acquired with no diﬀusion weighting for eight acquisitions
(i.e. b = 0 s mm−2) followed by 25 non-collinear diﬀusion gradient
directions and the negative of those diﬀusion gradient directions.
Axial FLAIR images: acquisition matrix = 256× 192, FOV= 240
× 240 mm2, TI = 2200 ms, TE= 130 ms, TR= 9000 ms; slices = 28,
slice thickness = 5mm providing a voxel resolution of 0.45× 0.45
× 5mm3.
Spoiled gradient echo recalled T1-weighted (SPGR) 3D coronal se-
quence: image acquisition matrix = 256× 192, FOV= 240× 240 mm2,
TE= 5ms, TR= 11.5 ms, ﬂip angle = 18°, slices = 176 coronal slices,
slice thickness = 1.1 mm, providing isotropic voxel resolution of 1.1 mm3.
Axial T2*-weighted gradient echo: acquisition matrix = 256× 192,
FOV= 240× 240 mm2, TE = 30 ms, TR= 300 ms, ﬂip angle = 15°, 28
slices, slice thickness = 5 mm.
2.3. Magnetic resonance image analysis
2.3.1. Diﬀusion-weighted image pre-processing
Following realignment of diﬀusion-weighted images to remove eddy
current distortions using the FSL Linear Image Registration Tool
(FLIRT, FMRIB Software Library, www.fmrib.ox.ac.uk/fsl) (Jenkinson
and Smith, 2001), the acquired positive and negative diﬀusion gradient
direction images (b = 1000 s/mm2) were geometrically averaged to
eliminate gradient cross-terms (Neeman et al., 1991). The eight images
without diﬀusion weighting (b= 0 s/mm2) were co-registered and
averaged to give a T2-weighted echo planar image, henceforth referred
to as the b0 image. Diﬀusion tensor maps were computed at each voxel
using FSL DTIﬁt and isotropic p and anisotropic q maps were calculated
for input to the DSEG algorithm (as described in Section 2.4.2).
The b0 images were skull stripped using FSL brain extraction soft-
ware (BET: (Smith, 2002)) and the resulting brain mask applied to the p
and q maps. The cerebellum was removed using an automated pipeline:
i) a study speciﬁc template was generated by transforming the b0 image
of a representative subject (deﬁned as the participant with the median
ventricular CSF volume) into the Montreal Neurological Institute stan-
dard space (i.e. MNI152 T1-weighted image) using a non-linear trans-
form computed using Advanced Normalisation Tools (ANTS: (Avants
et al., 2009)); ii) a mask covering the cerebellum and infratentorial
brain stem was manually drawn over the study speciﬁc template using
ITK-SNAP (Yushkevich et al., 2006); iii) each subject b0 image was non-
linearly registered to the study speciﬁc template using ANTS and the
inverse of this deformation ﬁeld was used to warp the cerebellum mask
into each individual native subject space; iv) any p and q voxels covered
by the native space cerebellum masks were removed.
2.3.2. Diﬀusion segmentation (DSEG) technique
Despite the prevalent use of DTI metrics, particularly FA as a marker
of WM microstructure, the FA measurement does have limitations. Due
to the way in which FA is calculated, proportional diﬀerences in the
Euclidian magnitude of a tensor and the magnitude of its anisotropic
component will result in the same FA value (Green et al., 2002) and
consequently a given FA value will not be unique. This introduces a
certain level of ambiguity in the interpretation of FA values for
Table 1
Cerebral small vessel disease baseline risk factors and cognitive scores. A comparison between the longitudinal cohort and those that left the study after baseline assessment. Mean
(standard deviation) or total (percentage) are shown.
Longitudinal cohort (n = 98) Baseline only (n = 23) Test statistic
Age (years) 69.0 (9.93) 74.2 (7.76) t(40.8) =−2.7, p= 0.009
Male sex 65 (66.3%) 13 (56.5%) OR = 1.51, p= 0.500
Hypertension 91 (92.9%) 21 (91.3%) OR = 0.81, p= 0.700
Statin therapy 84 (85.7%) 19 (82.6%) OR = 0.79, p= 0.700
Diabetes 19 (19.4%) 5 (21.7%) OR = 1.15, p= 0.800
Body mass index (kg/m2) 27.0 (5.19) 27.1 (3.08) t(44.7) =−0.1, p= 0.900
Current smoker 33 (33.7%) 9 (39.1%) p= 0.800
Time since stroke (weeks) 26 (13.16) 104 (16.31) Z=−1.82, p= 0.069
Executive function z-scores −0.77 (1.00) −1.5 (0.91) t(34.6) = 3.40, p= 0.002
Information processing speed z-scores −0.74 (0.89) −1.1 (1.00) t(28.5) = 1.60, p= 0.120
Signiﬁcant results are shown in bold.
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comparisons between participants, diﬀerent tissue types or regions of
interest. An alternative diﬀusion tensor decomposition represents iso-
tropic (p) and anisotropic (q) components of the tensor as described by
Pierpaoli and Basser (1996) and these are calculated as follows:
=p MD3 , (1)
= − + − + −q λ MD λ MD λ MD( ) ( ) ( ) ,1 2 2 2 3 2 (2)
where
= + +MD λ λ λ
3
.1 2 3
(3)
Here, p is a scaled measure of the mean diﬀusivity and q is a mea-
sure of the deviation of the principal diﬀusivities from isotropy. These
measures may be visualised in a 2D Cartesian plane, the (p, q) space, in
which p and q have units in mm2 s−1 (Peña et al., 2006) in a way that
allows for diﬀerentiation of the diﬀusion properties of GM, WM tissue
and cerebrospinal ﬂuid (CSF).
Using this alternative (p, q) space representation of DTI data, Jones
et al. (2014) developed and applied a novel DTI segmentation algo-
rithm, DSEG. DSEG uses a k-medians cluster analysis to segment DTI
data into 16 segments based on the magnitudes of the isotropic (p) and
anisotropic (q) diﬀusion metrics for each voxel. Each segment describes
a unique diﬀusion proﬁle that represents the tissue microstructural
properties of each voxel assigned to that segment. This allows diﬀer-
ences in the underlying isotropic and anisotropic diﬀusion character-
istics to be determined and compared between segments. The location
of each segment can be used to identify brain regions with similar
diﬀusion properties.
Once the segmentation is complete, the number of voxels assigned
to each segment and/or the percentage of cerebral volume assigned to
each segment can be computed, allowing the composition diﬀusion
characteristics of the whole brain to be displayed as a spectrum for a
given DTI dataset. This spectral information provides a signature dif-
fusion proﬁle containing information pertaining to GM and WM tissue,
CSF, and also includes regions with diﬀusion proﬁles that deviate from
those of healthy tissue. By considering the DSEG spectra as 16-dimen-
sional vectors it is possible to calculate a summary metric as the scalar
product, θ, between individuals. This summary metric can describe
inter-subject diﬀerences in whole brain diﬀusion with respect to a re-
ference brain, identiﬁed based on either behavioural or MRI measures.
In the present study, DSEG was performed simultaneously for all
participants from the GENIE and SCANS studies using p and q maps as
described by Jones et al. (2014). DSEG performs a k-medians clustering
of the probability density function (i.e. 2D histogram) of p and q and is
represented in (p, q) space. A k-medians algorithm was used (as op-
posed to k-means) as the 2D histogram of p and q values were non-
Gaussian allowing the cluster centroids to be deﬁned by the median.
As in Jones et al. (2014) k= 16 clusters are segmented. Each cluster
provides a diﬀerent characteristic diﬀusion property ranging from low
anisotropy and isotropy (i.e. low p and q values mainly found in grey
matter), high anisotropy and low isotropy (usually found in white
matter) to high anisotropy and low isotropy (usually found in CSF).
Fig. 1. The result of DSEG segmentation of the whole brain in the SCANS SVD cohort. (a) Shows the 2D histogram of p and q proﬁles from the whole longitudinal cohort, including healthy
ageing individuals. (b) Shows the segmented (p, q) space. (c) Represents the 2D-histogram of p and q values for diﬀerent tissue classes (GM: red, WM: blue, CSF: green &WMH: white). (d)
Shows the probability maps showing the location in standard space that each segment is most likely to be found in the cerebrum, grouped into GM (grey box), WM (white box), CSF
(dashed white line box), GM/CSF boundary (yellow box) and damaged tissue segments (red box). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
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However, it is important to note that the DSEG is not an explicit tissue
type segmentation and instead clusters voxels with similar diﬀusion
properties. The choice of k= 16 clusters is pragmatic and is based on a
optimising a balance between s separation of (p, q) space while
avoiding over complication and statistical power issues by having too
many segments. This is described in detail by (Jones, 2012).
The following steps describe the application of k-medians clustering
to p and q maps:
Step 1: Histograms of p and q were computed using all brain voxels
from the cross-sectional GENIE and longitudinal SCANS data. High and
low intensity noise was removed from each distribution by computing
the 1st and the 99.99th percentiles and assigning values below and
above these thresholds to zero or one, respectively. Voxels surviving
this threshold were then scaled between zero and one, resulting in non-
Gaussian p and q histograms of the whole data set (Fig. 1a).
Step 2: p and q maps are considered as a set of observations (X1, X2,
… Xn) where each observation is a 2D vector in (p, q) space. K-
medians clustering partitions the observations into k disjoint subsets
Sj, where j= (1, 2, … k) by minimising the within-cluster sum of
squares objective function,
∑ ∑= −
= ∈
J X μ‖ ‖ ,
j
K
n S
n j
1
2
j (4)
where Xn is a vector representing the nth data point and μj is the geo-
metric centroid (i.e. median) of the data points in Sj. The initial clusters
were deﬁned by separating the (p, q) space into k clusters of roughly
equal size according to median and quartile values of p and q. These
initial segments reﬂect the non-Gaussian structure present in the p and
q histograms (Fig. 1a).
The following two steps are repeated to iteratively assign all voxels
to one of k clusters and then recalculate cluster centroids.
Step 3: Each voxel was assigned to the nearest cluster centroid in (p,
q) space. As a result voxels are partitioned into k clusters given
below at the tth iteration,
= − ≤ − ∈ …∗∗S X X μ X μ i i k{ : ‖ ‖ ‖ ‖ for all , {1, , }}.i t j j i t j i
t( ) ( ) ( )
(5)
Step 4: Median p and q values are recalculated.
The DSEG algorithm is terminated when there is no longer any
movement of voxels between clusters or at 250 iterations, at which
point voxel classiﬁcation of diﬀusion properties across the diﬀerent
segments is stable. The resulting segmentation of (p, q) space is re-
presented in the Voronoi plot shown in Fig. 1b. Fig. 1c shows the (p, q)
histogram distributions for voxels separated by the following tissue
classes as segmented using methods described by Lambert et al. (2015);
GM (red), WM (blue), WMH (white) and CSF (green). Comparison of
Fig. 1b and c show how the DSEG segments map onto these basic tissue
types.
2.3.3. DSEG probability maps
DSEG maps were transformed into the study speciﬁc template space
and the mean spatial placement of each segment was calculated over
the whole cerebrum to provide maps showing the likelihood of diﬀu-
sion proﬁles being located in each brain voxel (i.e. a spatial probability
map). These probability maps are shown in Fig. 1d and add support to
the interpretation of DSEG segments having diﬀusion proﬁles that re-
present diﬀerent tissue types.
Fig. 2. Two examples of how DSEG colour maps are generated using the scaled rank scores of signal from T2-weighted, p and q images. (a) Represents the DSEG map of the youngest
healthy subject (56 years) used as the reference brain in DSEG θ calculations. (b) Represents age-matched subject with SVD (56 years). The orange arrow shows how the corpus callosum
is represented by segment 8 while the red arrows highlight areas identiﬁed as WMH on FLAIR images represented by segments 15 and 16. The green arrow indicates greater volume of
CSF space in the sulci in the SVD patient compared to the control. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this
article.)
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2.3.4. DSEG colour maps
DSEG maps were visualised using a unique RGB colour scheme to
display the relative magnitude of p and q metrics and T2-weighting
(obtained from the b0 maps) in each segment (Jones et al., 2014). The
median values for p, q and T2-weighting within each segment were
ranked from 1 (lowest) to 16 (highest) and the rank scores were used to
generate RGB colours by assigning T2-weighting to the red channel, p to
the green channel and q to the blue channel. Colour maps were vi-
sualised using MRIcro (Rorden and Brett, 2000). Fig. 2 illustrates how
isotropic and anisotropic diﬀusion measures are combined with in-
formation from T2-weighted images and visualised for the youngest
healthy subject (Fig. 2a: age 56 years from the GENIE study) and an age
matched SVD patient (Fig. 2b: age 56 years). DSEG colour maps provide
visual information about the diﬀusion properties within the tissue mi-
crostructure at each voxel. Orange arrows in Fig. 2 indicate the highly
organised corpus callosum, which is characterised by high anisotropy
and low isotropy as represented by segment 8 on the Voronoi plot
(Fig. 1b) and the highlighted area for the segment 8 probability map
(Fig. 1d). Red arrows indicate WMH regions (identiﬁed on FLAIR) on
the DSEG colour map (Fig. 2b). These WMH regions are characterised
by grey colours (segments 15 and 16 on the Voronoi plot, Fig. 1b) and
represent white matter regions with lower anisotropy and higher iso-
tropy than healthy white matter tissue.
2.3.5. DSEG whole brain spectra
To generate individual DSEG spectra for each participant, the
number of cerebrum voxels within each DSEG segment was determined
and the percentage contribution of each segment to the total cerebrum
volume was calculated. This provides a subject speciﬁc diﬀusion proﬁle
referred to as a DSEG spectrum.
2.3.6. DSEG summary metric
The angle, θ, between two vectors A=(a1,a2,…,a16) and B=
(b1,b2,…,b16) may be given by the scalar product,
= ⎛
⎝
∙ ⎞
⎠
−θ A B
A B
cos
‖ ‖‖ ‖
,1
(6)
Eq. (6) provides a summary metric for the diﬀerence between two DSEG
spectra that are represented by vectors A and B.
To ensure the metrics may be compared across subjects, vector A,
was chosen to represent the DSEG spectrum representing the ‘least
damaged’ brain. This reference brain was identiﬁed using an iterative
algorithm. Initially, θ was calculated between a randomly selected
DSEG spectrum (labelled vector A) and each remaining spectrum in the
dataset (labelled vector B). The spectrum with maximum θ was iden-
tiﬁed and relabelled as vector A. The process was repeated until vector
A oscillated between two DSEG spectra (i.e. the spectra of the “least”
and “most damaged” individuals). We identiﬁed vector A to represent
the “least damaged” individual. This corresponded to the DSEG spec-
trum of the youngest participant in the GENIE sample (aged 56 years).
Vector B was then used to represent the DSEG spectra for each in-
dividual at each time point in order to calculate θ for all individuals at
each time point. The scalar product method is similar to the functional
correlation measures used in several resting state functional MRI stu-
dies (Van Dijk et al., 2010).
2.4. Conventional image analysis
To allow comparison of the performance of the DSEG θ measure to
conventional imaging biomarkers in SVD several measures were de-
termined from the T1-weighted, FLAIR and T2*-weighted images as
well as conventional DTI histogram measures. Measures included total
cerebral volume (TCV), white matter hyperintensity lesion load (WMH
load), number of lacunes and number of cerebral microbleeds (CMB).
2.4.1. Structural pre-processing
A longitudinal tissue segmentation pipeline optimised to our
symptomatic SVD cohort was performed to obtain tissue probability
maps for GM, normal appearing white matter (NAWM), WMH and CSF
from FLAIR and T1-weighted images. This is described in detail in
Lambert et al. (2015) and Zeestraten et al. (2016) and provides total
cerebral volume, WMH load and number of lacunes.
2.4.2. Total cerebral volume
Volumes of GM, NAWM and WMH were calculated in the native
space from a hard segmentation of the tissue probability maps. For each
participant and time point TCV in millilitres was calculated as the sum
of GM, NAWM and WMH volumes.
2.4.3. WMH load
WMH load for each patient and time point was calculated as the
percentage of WMH volume within the TCV. WMH volume was calcu-
lated from the hard segmentation of the tissue probability maps. The
performance of the ﬁnal semi-automated binary thresholding of the
WMH tissue probability maps segmentation maps provided an intra-
class correlation coeﬃcient of 0.99 across a subset of 20 randomly se-
lected patients by two raters, EAZ and CL.
2.4.4. Lacunes
A consultant neuroradiologist (ADM) evaluated T1-weighted and
FLAIR scans for lacunes. To ensure an underlying SVD aetiology of la-
cunes and exclusion of perivascular spaces the lacunes were deﬁned as
CSF ﬁlled cavities of 3–15 mm in diameter with a surrounding rim of
FLAIR hyperintensity (Wardlaw et al., 2013a, 2013b). Follow-up scans
for each patient were registered to a group average template, as de-
scribed in Lambert et al. (2015), allowing accurate identiﬁcation of
incident lacunes. Lacune numbers at each time point were determined.
Lacune reliability metrics were checked across a subset of 20 randomly
selected patients assessed by the consultant neuroradiologist (ADM)
and an additional rater (EAZ) and provided an intra-class correlation
coeﬃcient of 0.99.
2.4.5. Cerebral microbleeds
CMB were deﬁned as homogeneous round focal areas <10 mm in
diameter of low signal intensity on T2*-weighted GRE images. Only
CMB meeting the Brain Observer Microbleed Rating Scale (BOMBS)
(Cordonnier et al., 2009) criteria for “certain” CMB were analysed.
Presence and number of new CMB were noted for all patients. All
baseline CMB were identiﬁed by a single consultant neuroradiologist
(ADM). CMB on follow-up were identiﬁed by a single rater (EAZ). Using
scans of a subset of 10 randomly selected patients that were assessed by
both raters the intra-class correlation coeﬃcient was 0.99.
2.4.6. Conventional DTI histogram measures
Conventional DTI measure histograms were also computed for
whole brain WM (including both NAWM and WMH) as described in
Zeestraten et al. (2016). These included histogram measures calculated
for the mean diﬀusivity (MD) and fractional anisotropy (FA) metrics.
Normalised histograms were computed in a composite mask containing
NAWM and WMH. The WM tissue masks (in the native T1-weighted
image space) were co-registered to the b0 image using FMRIB Non-
linear Image Registration Tool (FNIRT) (Andersson et al., 2007). Based
on a diﬀusivity threshold, spurious CSF voxels within the WM masks
were removed (i.e. voxels with MD> 0.0026 mm2 s−1. Histograms of
MD (range 0–0.004 mm2 s−1, bin width 0.000004 mm2 s−1) and FA
(range 0–1, bin-width 0.001) histograms were computed and median
and normalised peak frequency (i.e. normalised peak height, NPH). The
NPH of MD has previously been identiﬁed as the most stable and sen-
sitive DTI histogram measure to change of tissue microstructure in SVD
(Zeestraten et al., 2016).
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2.5. Cognitive assessment
A battery of standardised neuropsychological tasks sensitive to the
cognitive impairments seen in SVD was carried out annually. Details of
the full assessment have been published previously (Lawrence et al.,
2013, 2015) but this study will only consider the domains shown to be
most severely aﬀected in SVD, namely EF and IPS (Lawrence et al.,
2013; Pantoni, 2010; Zhou and Jia, 2009) EF was measured by the Trail
Making Test, part B (Reitan, 1958), Letter Fluency (Delis et al., 2001),
and the modiﬁed Wisconsin Card Sorting Test (categories completed
and perseverative errors) (Nagahama et al., 2003). IPS was measured
by Digit Symbol Substitution (Wechsler, 1997), the Grooved Pegboard
Test (Klove, 1963; Mitrushina et al., 2005), and the BIRT Memory and
Information Processing Battery (BMIPB) Speed of Information Proces-
sing test: Participants were presented with a series of ﬁve two-digit
numbers and asked to identify the second to highest number in each
series. The measure derived from this test is the total of correctly
completed series within a four minute time limit, corrected for by the
time it takes to complete a matching motor task (Coughlan et al., 2007).
Individual measures were age-scaled using published normative data,
converted to z-scores and a mean composite cognitive domain score
was calculated within each domain (EF and IPS). Parallel test forms
were employed for two tests to reduce learning eﬀects: the B-MIPB
speed of information processing task (4 forms) and single letter verbal
ﬂuency (annually alternating F-A-S and B-H-R). All other tasks were
identical at each assessment. Premorbid intelligence (IQ) was assessed
using the National Adult Reading Test-restandardised (NART) (Nelson
and Willison, 1991) and the Mini Mental State Exam (MMSE) (Folstein
et al., 1975) was used as a dementia screening tool.
2.6. Statistical analysis
Baseline diﬀerences between patients who remained in the study
and those who left the study have been described before in Lawrence
et al. (2015). Analysis is replicated here. Welch's t-tests was used for
continuous variables, Fisher's exact test for categorical data (i.e.
smoking status) and odds-ratios for 2 × 2 categorical data.
Linear mixed-eﬀects (LME) models were applied using MLwiN
(Rasbash et al., 2009) and used to assess the eﬀects of time on change in
cognition, DSEG, DTI and structural markers. LME models were used
due to the hierarchical nature of the data, with each parameter having
multiple measurements per subject. The trajectories of each measure for
each individual were modelled as a linear trend across the follow-up
period as a function of time since baseline cognitive testing or scanning.
The intercept and slope of each participant's linear trajectory were al-
lowed to vary with both ﬁxed and random eﬀects. Fixed eﬀect variation
was accounted for by time, and random eﬀect variation allowed for
remaining inter-individual diﬀerences. The average ﬁxed eﬀects slopes
of time represent the average annualised change rate for a given mea-
sure. The change rates for each measure (cognitive or imaging) were
evaluated using the Wald test, which assesses the goodness of ﬁt be-
tween the observed values and the expected values (i.e. the modelled
slope). The Wald test takes on a χ2 distribution, which is used to cal-
culate the statistical signiﬁcance of each model.
LME models were also used to assess the relationships between
change in individual DSEG segmented and the whole cerebrum DSEG θ.
Further LME models were used to assess the relationships between the
eﬀects of change in imaging measures on cognitive domains, with ﬁxed
eﬀect variation being accounted for by change in MRI measures with
time. The average ﬁxed eﬀects slopes of MRI measures represent the
average annualised change rate for a given cognitive domain related to
one unit change in the MRI measure. Univariable models assessed the
impact of MRI markers on cognitive domains in the ﬁrst instance and
those markers that were signiﬁcantly related to change in cognition
were included in a set of multivariable analyses. This was to ensure that
only markers that are independently related to cognitive change were
included in multivariable models. Covariates including age, gender and
time since stroke were also only included if there were signiﬁcantly
related to EF or IPS in univariable analysis. For the secondary, multi-
variable analysis, a more conservative signiﬁcance level was set using
Bonferroni correction for multiple comparisons.
Post-hoc sample size estimations were performed for DSEG θ to
assess its potential use in a clinical trial setting. Sample size estimates
for the number of patients required at each time point in a 3-year an-
nual testing trial was calculated using the longpower statistical package
in R (version 3.02: www.R-project.org) (Liu and Liang, 1997). The
minimum sample sizes that were required to detect a change in the rate
of DSEG θ were estimated for eﬀect sizes of 30%, 25%, 20% and 15%. A
balanced trial was assumed with a power of 80% and α= 0.05.
3. Results
3.1. Baseline comparison between longitudinal cohort and those who did not
return for follow-up
Table 1 shows the baseline characteristics of the longitudinal cohort
(n = 98) compared to all patients who did not attend follow-up testing
(n = 23). The longitudinal cohort was signiﬁcantly younger (mean
age = 69.00, S.D. = 9.93) than the dropout group (mean age = 74.20,
S.D. = 7.76). The longitudinal cohort also performed signiﬁcantly
better in EF tasks (mean EF =−0.77, S.D. = 1.0) compared to the
dropout group (mean EF =−1.50, S.D. = 0.91). There were no other
signiﬁcant diﬀerences in baseline characteristics between the long-
itudinal cohort and the dropout group.
3.2. Brain tissue characterisation using DSEG maps
The ﬁnal segmentation of (p, q) space can be seen in Fig. 1b and p
and q median values for each DSEG segment are given in Supplemen-
tary Table 1. Fig. 1b and the accompanying probability maps in Fig. 1d
suggest that segments 1–4 represent GM and have characteristic diﬀu-
sion signatures with low p (isotropy) and low q (anisotropy). WM is
represented by segments 5–8, and have diﬀusion signatures with low p
and increasing q, identifying increasingly organised microstructure. For
example, more densely packed axons or uniform axonal orientation are
represented by segment 8 in the corpus callosum and the corticospinal
tracts. The CSF is represented by segments 9–11 with high isotropy
diﬀusion signatures. Segments 12–16 include voxels at tissue bound-
aries: segments 12–14 are at the boundary of cortex and CSF space and
segments 15–16 are located at the border between WM and the lateral
ventricles. These segments are likely to include tissue partial volume
eﬀects that may suggest GM (segments 1–4) and WM (segment 5–7)
atrophy. We deﬁne segments 12–16 as intermediate segments as they
represent diﬀusion characteristics that deviate from healthy tissue sig-
natures (i.e. with higher p and lower q than healthy white matter seg-
ments) and may indicate damaged or abnormal tissue.
3.3. DSEG spectra
Figs. 3 and 4 illustrate DSEG spectra for the reference brain (dotted
line) and an example of one individual who changed little (Fig. 3) or
changed substantially (Fig. 4) over the three year study period. As can
be seen in Fig. 3a, the spectra proﬁle of the SVD patients deviates from
the healthy ageing reference spectra particularly in segments 1–4 (re-
lating to GM) and segments 5–6 (relating to WM). However spectra of
the segments do not demonstrate a substantial change over the 4
available time points, as can be seen in the stability of DSEG θ (Fig. 3c).
Fig. 3b illustrates the spectra within WMH which is substantially dif-
ferent between the reference brain and the SVD patient. The diﬀerences
in WMH spectra are particularly pronounced in segments 5–8 (relating
to WM), but also in segment 2 (relating to deep GM) and segment 15 (at
the boundary of lateral ventricles). Fig. 4 illustrates an individual who
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changed substantially over the study period. Not only does the spectra
of this individual diﬀer from the reference spectra (Fig. 4a) in most
segments with the exception of segment 8 (representing highly orga-
nised corticospinal tracts), spectra also changed from baseline to Time
3. This diﬀerence is also observed in the summary metric DSEG θ
(Fig. 4c). Spectra within WMH diﬀer substantially from the reference
spectra particularly in segments 5–8 (representing WM) and segments
15–16 (boundary segments, see Fig. 4b), and also demonstrated sub-
stantial increase longitudinally. Table 2 shows the relationship between
change in DSEG segments as a percentage of total cerebrum volume and
the summary metric, DSEG θ. It can be seen that an increase in DSEG θ
is associated with a decrease in healthy GM (segments 1–4) and WM
(segments 5–7) and an increase in CSF space (segments 9–11), partial
volume tissue at the border of GM and CSF (segments 12–14), and an
increase in WMH related damage (segments 15 & 16). As such DSEG θ
successfully describes changes in microstructure over a three-year
period in one measure.
3.4. Linear mixed eﬀect models of cognitive and brain structural decline
over three years
Table 3 shows the ﬁxed eﬀects results of LME models of change in
cognition and imaging metrics over time. As time was measured in
years, the beta values indicate the average annual change for each
variable. Using this conservative estimation, neither EF nor IPS showed
signiﬁcant decline over a three-year period. In contrast, all MRI markers
demonstrated a signiﬁcant decline over three years. DSEG θ declined
signiﬁcantly, suggesting a decrease in whole brain microstructural
health causing the diﬀerence between individual DSEG spectra and that
of the reference brain becomes smaller. Decreases in WM micro-
structural integrity are apparent with signiﬁcant decreases in MD NPH
and FA median and an increase in MD median. FA NPH did not change
signiﬁcantly. WMH load increased over time while TCV decreased with
time, indicating increased levels of atrophy. In total 74 new lacunes
were observed in 27 patients, with a single new lacune being found in
10 patients, two new lacunes in nine patients and three or more in eight
patients. There were 173 new CMBS found in 35 patients with a single
new CMB found in 10 patients, 2–5 new CMBs found in 14 patients and
six or more CMBs found in 11 patients. New lacunes and CMB were log
transformed due to non-normal distributions in order to allow the in-
clusion of these metrics in LME models.
Table 4 shows the relationship between change in DSEG θ and
change in conventional markers of SVD and DTI histogram measures
related damage in LME models. DSEG θ was signiﬁcantly associated
with all conventional markers and DTI histogram measures suggesting
that as DSEG θ increases there are higher rates of atrophy, WMH load,
incident lacunes, CMB and a decline in WM microstructure.
3.5. Univariable linear mixed eﬀect models of the impact of change in brain
structure on change in cognition
Initial assessment of the impact of brain change on decline in cog-
nition was carried out using univariable LME models. Tables 5 and 6
show the results for EF and IPS in which the beta values are related to
the predicted change in a given cognitive domain for every unit change
in the MRI marker. For example, one degree increase in DSEG θ is
Fig. 3. An example of an individual who did not show steep increases in DSEG θ. At baseline this patient was 61 years old, 2.25 years since time of stroke, had an EF z-score of−1.79 and
an IPS z-score of−0.90. (a) Represents the DSEG spectra of the whole cerebrum at each time point and can be compared to the spectrum of the reference brain. The spectra show minimal
change, suggesting brain microstructure stability in this individual over time. (b) The spectra extracted from WMH show minimal change over time. In these graphs, the Reference brain
spectrum is indicated by the black dotted line, Baseline by the green line, Time 1 by the orange line, Time 2 by the blue line and Time 3 by the red line. (c) Example axial DSEG slices are
shown using the radiological convention at each time point with the corresponding DSEG θ value. As suggested by the spectra, changes in the DSEG images are minimal. (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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predicted to be associated with a change of−0.047 z-scores in EF. Thus
increases in DSEG θ will have a negative impact on EF performance
over time. Change in EF was also related to change in MD NPH, MD
median, FA median, TCV, and new lacunes. IPS was related to DSEG θ,
MD NPH, MD Median, FA NPH, FA median, new lacunes and CMBs.
Both cognitive domains were related to premorbid IQ; IPS was also
related to sex, but neither domains were related to age or years since
stroke.
(a) (b)
(c)
Fig. 4. An example of an individual who exhibited a steep increase in DSEG θ over time. At baseline this patient was 65 years old, 2.31 years since time of stroke, had an EF z-score of
−1.03 and an IPS z-score of−0.14. (a) Represents the DSEG spectra at each time point compared to the reference brain spectra. The spectra change each year, becoming more diﬀerent
to the reference. (b) The spectra extracted from WMH show change over time indicating an increase in the volume of WMH. In these graphs, the Reference brain spectrum is indicated by
the black dotted line, Baseline by the green line, Time 1 by the orange line, Time 2 by the blue line and Time 3 by the red line. (c) Example axial DSEG slices are shown using the
radiological convention at each time point with the corresponding DSEG θ value. As suggested by the spectra, changes in the DSEG images are substantial. (For interpretation of the
references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 2
LME results showing the relationships between annual change in DSEG segments and
change in DSEG θ. Beta values represent the average change in DSEG θ given a percentage
unit change for each segment. S.E. = standard error.
Segment Beta S.E. χ2, p
1 (GM) −1.173 0.097 146.533, <0.001
2 (GM) 1.278 0.220 33.861, <0.001
3 (GM) −2.357 0.090 685.551, <0.001
4 (GM) −0.388 0.270 2.058, 0.151, <0.001
5 (WM) −3.505 0.253 192.017, <0.001
6 (WM) −3.163 0.385 67.163, <0.001
7 (WM) −1.874 0.443 17.941, <0.001
8 (WM) −0.435 0.637 0.466, 0.495
9 (CSF) 2.411 0.173 194.149, <0.001
10 (CSF) 2.412 0.187 165.851, <0.001
11 (CSF) 1.255 0.255 24.202, <0.001
12 (GM/CSF border) 0.872 0.361 5.840, 0.016
13 (GM/CSF border) 3.351 0.300 124.895, <0.001
14 (GM/CSF border) 3.149 0.245 164.563, <0.001
15 (Damaged tissue) 2.028 0.171 140.636, <0.001
16 (Damaged tissue) 4.097 0.547 56.182, <0.001
Signiﬁcant results shown in bold, after Holm-Bonferroni correction.
Table 3
Linear mixed eﬀect models of change in cognition and magnetic resonance imaging
biomarkers over a period of three years. Beta values represent the average annual rate of
change for each variable, S.E. = standard error.
Beta S.E. χ2, p
Cognitive variables
EF −0.016 0.021 0.582, 0.445
IPS −0.005 0.019 0.079, 0.779
DSEG
θ 1.168 0.085 190.149, <0.001
DTI histogram measures
MD NPH −3.17 × 10−4 3.11e × 10−7 142.355, <0.001
MD median (mm2 s−1) 5.29 × 10−6 5.09 × 10−7 108.047, <0.001
FA NPH 6.84 × 10−7 5.08 × 10−6 0.018, 0.893
FA median −0.002 0.0004 28.802, <0.001
Conventional MRI measures
WMH load 0.773 0.064 145.748, <0.001
TCV (ml) −13,830.838 810.366 291.296, <0.001
Lacunes 0.019 0.004 17.703, <0.001
CMB 0.034 0.005 38.004, <0.001
Signiﬁcant results shown in bold.
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3.6. Multivariable linear mixed eﬀect models of change in MRI biomarkers
related to cognitive change
All MRI markers that were signiﬁcantly (p= 0.05, uncorrected)
related to a cognitive domain in univariable analysis were subsequently
entered into a multivariable analysis in order to assess the relative
contribution of each marker to cognitive change when all other markers
are controlled for. A multivariable LME model was created for EF and
IPS in turn, in which MRI markers and premorbid IQ, age and years
since stroke were included if they were signiﬁcantly related to each
cognitive domain.
3.6.1. EF
The multivariable model for EF is shown in Table 5. It can be seen
that the only MRI markers to remain signiﬁcant in the multivariable
model after correction for multiple comparisons was DSEG θ and
number of new lacunes. A degree change in DSEG θ predicted a−0.036
z-score change in EF. New lacunes was related to a −0.544 change in
EF, though the direct impact of each new lacune is unclear due to log
transformation of the data. Premorbid IQ was also related to change in
EF, where a unit increase in premorbid IQ predicted slower rate of
change in EF by 0.043 z-scores.
3.6.2. IPS
The multivariable model for IPS (shown in Table 6), demonstrated
that DSEG θ, and new lacunes were the only MRI markers signiﬁcantly
related to IPS after correction for multiple comparisons. A degree
increase in DSEG θ predicted −0.031 z-score change in IPS. A unit
change in lacunes predicted a change of −0.509 z-score in IPS. A unit
diﬀerence in premorbid IQ related change in IPS, where a unit increase
in premorbid IQ predicted slower rate of change in IPS by 0.019 z-
scores.
3.7. Post-hoc sample size estimates for DSEG θ
Table 7 shows the results of the post-hoc sample size estimates for
DSEG θ compared to the best performing conventional and diﬀusion
imaging markers of SVD progression previously reported in the same
SCANS data over 3-years (Benjamin et al., 2015 & Zeestraten et al.,
2016). Sample size estimates for DSEG θ are considerably lower than
those of MD NPH and WMH volume. For example, DSEG θ requires a
sample size of 73 to detect a 30% change in SVD progression compared
to 128 for MD NPH and 124 for WMH volume. This means that 41%
fewer patients are required within a clinical trial for which a 30%
change is expected when using the DSEG θ marker compared to WMH
volume and 42% fewer compared to MD NPH.
4. Discussion
In this study we demonstrate that a novel DTI segmentation, DSEG,
is a sensitive marker to assess the degree of brain damage in SVD.
Although DSEG has been previously applied to the study of brain tu-
mours, we demonstrate that it is also sensitive to subtle and gradual
brain changes observed in SVD. DSEG spectra demonstrate sensitivity to
individual diﬀerences in baseline measures as well as detecting diﬀer-
ences in the rates of change over a three-year period. Segments most
associated with tissue characteristics of GM and WM are shown to de-
viate from those characteristics of a healthy reference brain in SVD,
even when the patient then remains stable over the subsequent three-
year follow-up. For a patient with SVD who declines substantially over
the follow-up period, the DSEG spectra demonstrate proportional
changes in most segments, with a decrease in healthy GM and WM and
an increase in WMH associated damage and CSF ﬁlled space. As such,
DSEG can detect brain tissue changes characteristic of SVD.
As well as providing information about tissue diﬀusions character-
istics in spectra, DSEG also provides a summary metric (DSEG θ) that
characterises microstructural information derived from the whole
brain. As with DSEG θ, other standard MRI measures including those
from DTI histograms were sensitive to detect brain changes over the
three-year follow-up. In contrast, cognitive function measured by EF
and IPS did not demonstrate a signiﬁcant decline in this analysis. This is
in keeping with a previous report of no cognitive decline in patients
Table 4
Univariable linear mixed eﬀect models of change in DSEG θ related to change in con-
ventional magnetic resonance imaging biomarkers of SVD and DTI histogram measures
over a period of three years.
Beta S.E. χ2, p
DTI histogram measures
MD NPH −1169.333 140.115 69.648, <0.001
MD median (mm2 s−1) 81,309.227 8070.304 101.508, <0.001
FA NPH 4813.334 857.420 31.514, <0.001
FA median (mm2 s−1) −28.673 11.997 5.712, 0.017
Conventional MRI markers
WMH load 0.479 0.136 12.341, <0.001
TCV (ml) 1.48 × 10−5 5.40 × 10−6 7.492, 0.006
Lacunes 5.015 1.255 15.967, <0.001
CMB 2.636 1.037 6.470, 0.011
Signiﬁcant results shown in bold.
S.E. = Standard error.
Table 5
Univariable and multivariate linear mixed eﬀect models of executive function change related to change in magnetic resonance imaging biomarkers.
EF Univariable models Multivariable MRI and IQ
Beta (S.E.) χ2, p Beta (S.E.) χ2, p
DSEG θ −0.047 (0.010) 23.205, <0.001 −0.036 (0.011) 11.208, <0.001
MD NPH 79.6 (28.400) 7.860, 0.005 23.288 (38.009) 0.375, 0.540
MD Med (mm2 s−1) −4.91 × 103 (1.86 × 103) 6.980, 0.008 3232.074 (2881.822) 1.258, 0.262
FA NPH −123.073 (227.579) 0.295, 0.0587 a a
FA Med (mm2 s−1) 4.999 (2.551) 3.840, 0.050 −0.531 (3.973) 0.018, 0.894
WMH load −0.051 (0.027) 3.488, 0.062 a a
TCV (ml) 2.17 × 10−6 (8.84 × 10−7) 6.060, 0.014 1.01 × 10−6 (6.74× 10−7) 2.236, 0.135
Lacunes −0.606 (0.210) 8.302, 0.004 −0.544 (0.175) 9.613, 0.002
CMB −0.328 (0.172) 3.636, 0.057 a a
Age −0.012 (0.010) 1.286, 0.257 a a
IQ 0.045 (0.005) 76.880, <0.001 0.043 (0.005) 90.733, <0.001
Sex −0.284 (0.219) 1.681, 0.194 a a
Years stroke −0.037 (0.021) 3.058, 0.080 a a
Signiﬁcant results shown in bold.
S.E. = standard error.
a Indicates variable was not included in multivariable model.
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with lacunar stroke followed for an average of three-years (Pearce et al.,
2014). This may reﬂect the fact that MRI measures are more sensitive to
decline in SVD patients when compared to cognitive measures. Alter-
natively, after the initial brain pathology that results in ‘caseness’ re-
garding the lacunar infarct condition and accompanying cognitive
deﬁcit, there may be a period in which there are further white matter
brain changes, but cognition remains relatively stable. Additionally, the
lack of longitudinal cognitive decline may also reﬂect in part learning
eﬀects when cognitive measures are repeatedly administered in long-
itudinal studies (Dikmen et al., 1999; Ferrer et al., 2005; Ferrer et al.,
2004; Wilson et al., 2006).
One diﬀerence between the present study and previous investiga-
tions presenting derivations and investigation of total SVD burden
scores is that we present a single measure derived from a single imaging
modality rather than measures obtained from diﬀerent MRI markers of
SVD. For example, (Huijts et al., 2013; Klarenbeek et al., 2013, and
Staals et al. (2014, 2015) previously used information from lacunar
infarcts, WMH, CMB and enlarged perivascular spaces to obtain SVD
burden scores. Our SVD burden score, DSEG θ, was related to all four
conventional MRI markers of SVD used in this study (WMH load, TCV –
representing cerebral atrophy, new lacunes and CMB), with an increase
in DSEG θ being associated with higher SVD burden as measured by
these markers. Furthermore, our SVD burden score was related to WM
tissue microstructural histogram measures. An additional beneﬁt of the
DSEG technique, as also for the technique of Staals et al. (2015) which
generated a latent variable from the full range of SVD markers, is that
we also construct a summary variable that is not derived from dichot-
omised scores for SVD burden.
In this study linear mixed eﬀects models were used as they allow for
powerful exploration of the relationships between several hierarchical
variables with multiple measures. LME allow for random variation at
the individual level while ﬁxed eﬀects of time are taken in to account.
This is in contrast to our previous paper using the SCANS cognitive data
(Lawrence et al., 2015) in which three-year change was explored using
linear regression analysis in which signiﬁcant decline in EF was found.
The rigorous statistical tests employed in the current study did not ﬁnd
signiﬁcant decline in EF but this is likely due to the more conservative
estimates of change imposed by LME analysis. However LME did allow
full exploration of the relationships between change in brain markers
and individual diﬀerences in gradients of cognitive function change
despite the observation of no signiﬁcant decline over the testing period.
Despite the lack of a signiﬁcant decline in cognitive function, univari-
able analysis demonstrated strong associations between change in MRI
markers and change in cognition. For both EF and IPS, change in DSEG
θ, standard DTI histogram metrics, and lesion measures (WMH load,
lacunes, CMB), were associated with change in cognition. These results
are in agreement with previous reports of change, with changes in DTI
metrics, atrophy and incident lacunes being related to longitudinal
decline in cognitive scores that measure attention, processing speed, EF
and episodic memory (Jokinen et al., 2011, 2012; van Uden et al.,
2015; van Norden et al., 2012). However, multivariable analyses de-
monstrate that DSEG θ remained a signiﬁcant predictor of change in EF
and IPS while standard MRI measures provided no further information,
with the exception of new lacunes. Premorbid IQ contributed sig-
niﬁcantly to models for both EF and IPS suggesting a strong link be-
tween cognitive reserve (Stern, 2002) and subsequent impact of SVD on
cognitive change. As premorbid IQ was positively related to cognition,
this suggests that the more cognitive reserve present before onset of
disease, the less the disease will aﬀect cognition i.e. cognitive reserve
serves as a protecting factor against cognitive decline.
In the LME models presented here, DSEG θ provides a very stable
measure of microstructural brain change, as is shown by the highly
signiﬁcant goodness of ﬁt (as assessed by the Wald test). As a result,
when DSEG θ is considered in conjunction with other less stable MR
markers in multivariable analysis, it provides the strongest predictor of
cognitive change, in part because it has less noise in the model than
other MR variables. In post-hoc sample size analysis, DSEG θ provided
low sample size estimates ranging from 73 patients to detect a 30%
treatment eﬀect and 290 patients to detect a 15% treatment eﬀect. This
was compared to the sample size estimates for WMH volume and MD
NPH, reported previously for the same SCANS patient sample over the
same testing period (3-years). The results for these metrics were com-
pared to DSEG θ because they provided the optimum sample size me-
trics for conventional MRI markers and DTI histogram markers of SVD
progression (Benjamin et al., 2015 & Zeestraten et al., 2016). Compared
to these, DSEG θ could detect the same change with 41–42% fewer
Table 6
Univariable and multivariate linear mixed eﬀect models of information processing speed change related to change in magnetic resonance imaging biomarkers.
IPS Univariable models Multivariable MRI and IQ
Beta (S.E.) χ2, p Beta (S.E.) χ2, p
DSEG θ −0.029 (0.008) 14.5, <0.001 −0.031 (0.010) 10.648, 0.001
MD NPH 60.842 (22.958) 7.023, 0.008 3.071 (34.759) 0.008, 0.930
MD Med (mm2 s−1) −3528.697 (1503.716) 5.510, 0.019 7063.002 (2775.184) 6.477, 0.011
FA NPH −591.526 (180.716) 10.714, <0.001 −496.639 (212.073) 5.484, 0.019
FA Med (mm2 s−1) 4.796 (2.041) 5.523, 0.019 5.869 (3.437) 2.916, 0.088
WMH load −0.033 (0.022) 2.311, 0.128 a a
TCV (ml) 7.99 × 10−7 (7.1 × 10−7) 1.270, 0.260 a a
Lacunes −0.715 (0.160) 19.934, <0.001 −0.509 (0.165) 9.497, 0.002
CMB −0.275 (0.143) 3.719, 0.054 0.028 (0.144) 0.037, 0.847
Age 0.015 (0.008) 3.665, 0.056 a a
IQ 0.021 (0.005) 17.778, <0.001 0.018 (0.004) 19.578, <0.001
Sex −0.482 (0.163) 8.733, 0.003 −0.337 (0.137) 6.087, 0.014
Years stroke −0.022 (0.025) 0.809, 0.368 a a
Signiﬁcant results shown in bold.
S.E. = standard error.
a Indicates variable was not included in multivariable model.
Table 7
The predicted minimum sample size for a hypothetical trail of three-year duration as-
suming a balanced design with DSEG measurements taken annually to test a hypothetical
treatment eﬀect of 30, 25, 20 and 15% on the rate of DSEG θ change. For comparison, MD
NPH and WMH volume values are also shown, taken from Benjamin et al. (2015) and
Zeestraten et al. (2016).
Hypothetical treatment eﬀects
30% 25% 20% 15%
DSEG θ sample size 73 104 163 290
MD NPH (Zeestraten et al., 2016) 128 185 325 578
WMH volume (Benjamin et al., 2015) 124 178 279 496
O.A. Williams et al. NeuroImage: Clinical 16 (2017) 330–342
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patients in a clinical trial. These results suggest DSEG θ can be used as a
clinical tool with a high degree of conﬁdence that it will be sensitive to
changes in SVD related brain structure.
The stability of DSEG θ is likely the result of all analysis being
carried out in DTI native space across the entire cerebrum whereas DTI
histogram measures rely on a hard segmentation of WM tissue that is
dependent on a co-registration with a structural T1-weighted image and
accurate automatic segmentation of GM and CSF boundaries, this will
introduce noise in the data by including partial volume voxels at the
border of the WM tissue mask images. DSEG is also an automatic seg-
mentation technique and thus avoids any noise associated with manual
segmentation and identiﬁcation errors for WMH, lacunes and CMB.
These results are similar to a recent report of a novel marker of SVD
using the peak width of the skeletonised mean diﬀusivity (PSMD:
Baykara et al., 2016) in which the DTI-derived marker demonstrated
the strongest relationship with IPS in comparison to WMH volume,
lacune volume and brain volume. However, DSEG may have the beneﬁt
of using information from the whole cerebrum (rather than WM only)
and of incorporating both isotropic and anisotropic diﬀusion informa-
tion rather than just MD. Furthermore, DSEG does not require any
transformations of DTI data onto a skeletonised mean MD map,
avoiding the introduction of noise through co-registration errors.
A limitation of the current analysis is that spatial information de-
scribing the location of SVD pathology has not been taken into account.
It has already been highlighted by Staals et al. (2015) that SVD burden
scores tend to neglect location information related to lacunes and CMB
which have been shown to be important when exploring relationships
between SVD markers and cognitive decline (Benisty et al., 2009; Poels
et al., 2012). Future application of DSEG should address this by ex-
amining DSEG θ metrics by brain region or by combining DSEG with
voxel based analysis. However, the current study demonstrates that
DSEG provides a measure of SVD severity across the whole cerebrum,
using a single imaging modality, without the need for co-registration of
images across time points or into standard space, which would be ne-
cessary for more complex spatial analysis.
A further limitation is that the longitudinal cohort examined in this
study is younger and less cognitively impaired compared to those pa-
tients who dropped out of the study after baseline testing. This suggests
that there may be a selective attrition eﬀect (Salthouse, 2009) in which
patients who are least eﬀected by the disease are more likely to remain
in the study. This has implications for the generalizability of these re-
sults to all patients of SVD and suggests that the ﬁndings presented here
are most applicable to those in the earlier or less severe stages of the
disease. However, as DSEG θ has been shown to be sensitive to SVD
progression in these “less aﬀected” individuals, it is likely to be a useful
tool in more severe cases of SVD as well.
As DSEG is related to all conventional MRI markers of SVD con-
sidered in the present study and is signiﬁcantly associated with EF and
IPS in predictive models, it may be used as a surrogate marker of SVD
severity. By reducing whole cerebrum information to a single measure,
DSEG θ can be used as a tool that avoids statistical power limitations
due to multiple comparisons on a voxel or regional basis. DSEG mea-
sures have previously been shown to have good between site reprodu-
cibility (Jones et al., 2014), making DSEG θ a promising tool for large
multi-site studies of SVD. Furthermore, sample size estimates suggest
that DSEG θ has potential as a clinical tool, capable of detecting the
eﬀects of potential interventions with a high degree of conﬁdence.
Taken together, the promising performance of DSEG suggests that it
could be a powerful tool for clinical trials, monitoring, and predicting
disease progression in SVD patients as it shows strong relationships
with the cognitive domains aﬀected most by the disease.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2017.08.016.
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